David Perlman, MD
img_David Perlman
PROFESSOR | Medicine, Infectious Diseases
Are you a patient?
Specialties
Infectious Disease
Research Topics
Addiction, Biomedical Sciences, Epidemiology, Global Health, HIV/AIDS, Hepatitis C Virus, Infectious Disease

His earlier work focused on studies of the epidemiology of tuberculosis among drug users, and on health care delivery models and behavioral and structural interventions to facilitate adherence to the TB care continuum. Recent work has focused on the delivery of other health care services (HIV, STI, HCV, HBV, others) to drug users in and out of drug abuse treatment, a qualitative and quantitative study of barriers and facilitators of HIV and HCV testing and care among ethnic minority drug users, and a “seek, test, treat and retain” intervention for high risk heterosexuals.  A prominent line of inquiry has been improving adherence to multi-step heath care interventions and care continua in a variety of settings, including extensive work with drug using populations in and out of drug abuse treatment settings. His current work focuses on the HCV care continuum. He was PI of the NIDA funded “Bridges” project, an RCT of a combined case management-motivational interviewing intervention to promote adherence to off-site referral for HCV care from methadone maintenance treatment (published in AJPH and selected for the AHRQ New Innovations Exchange). He is actively involved in a number of ongoing projects.

MD, Yeshiva University Albert Einstein College of Medicine

BA, Dartmouth College

Residency, Internal Medicine, Memorial Sloan-Kettering Cancer Center

Fellowship, Infectious Disease, Albert Einstein College of Medicine-Yeshiva University

Certifications

American Board of Internal Medicine

2012

Best Doctors 2012, 2013, 2014, 2016, 2017 & 2018

NY Magazine

2005

President, Infectious Diseases Society of New York

2000

TB Committee, Infectious Disease Society of

Fellow, Infectious Disease Society of America

College on Problems of Drug Dependence

The Leo M. Davidoff Society - for excellence in teaching

Super Doctors 2014, 2015, 2017 & 2019

Conceptualizing Care Continua

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Perlman has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.